Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
ranibizumab allowed
ranibizumab tillatt
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
group i ranibizumab
gruppe i ranibizumab 0,5 mg
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ranibizumab 0.5 mg (n=130)
simulert injeksjon /ranibizumab 0,5 mg (n=130) ranibizumab 0,5 mg (n=130)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 vial = 2.3 mg ranibizumab.
1 hetteglass = 2,3 mg ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each ml contains 10 mg ranibizumab.
hver ml inneholder 10 mg ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
one ml contains 10 mg ranibizumab*.
Én ml inneholder 10 mg ranibizumab*.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
one ml contains 10 mg of ranibizumab.
Én ml inneholder 10 mg ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vial containing 2.3 mg of ranibizumab.
hvert hetteglass inneholder 2,3 mg ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ham-controlled arm crossed-over to ranibizumab
simulert -kontrollert arm krysset over til ranibizumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
it contains the active substance called ranibizumab.
det inneholder det aktive virkestoffet kalt ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lucentis 10 mg/ml solution for injection ranibizumab
lucentis 10 mg/ml injeksjonsvæske, oppløsning ranibizumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance is ranibizumab (10 mg/ml).
virkestoff er ranibizumab (10 mg/ml).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
for ranibizumab no clinical data on exposed pregnancies are available.
for ranibizumab foreligger ingen kliniske data på bruk under graviditet.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ranibizumab 0.5 mg group i by stabilisation (n=105)
ranibizumab 0,5 mg gruppe i ved stabilisering (n=105)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each vial contains 2.3 mg of ranibizumab in 0.23 ml solution.
hvert hetteglass inneholder 2,3 mg ranibizumab i 0,23 ml oppløsning.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bilateral intravitreal administration of ranibizumab to cynomolgus monkeys at doses between
bilateral intravitreal administrering av ranibizumab til cynomolgus-aper med doser på mellom
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
crystal was a single-arm study with 0.5 mg ranibizumab monotherapy.
crystal var en studie med 1 behandlingsgruppe med 0,5 mg ranibizumab som monoterapi.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the safety and efficacy of ranibizumab have not yet been studied in paediatric patients.
sikkerheten og effekten av ranibizumab har ikke blitt studert hos pediatriske pasienter.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lucentis 10 mg/ml solution for injection in pre-filled syringe ranibizumab
lucentis 10 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte ranibizumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
after 6 months, patients in the sham-control arms switched to 0.5 mg ranibizumab
etter 6 måneder ble pasientene i kontroll-armen med simulerte injeksjoner byttet til 0,5 mg ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: